Hospira Inc. recalls Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospir
Recalled May 31, 2017 · FDA recall D-0862-2017 · Hospira
Hazard
Presence of Particulate Matter: human hair found within an internal sample syringe. · FDA Class I
Units
71,550 syringes
Sold at
Nationwide in the USA and Puerto Rico
Description
Presence of Particulate Matter: human hair found within an internal sample syringe.
Product
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10
Manufacturer(s)
Hospira Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →